Department of Pathology, University of California, 513 Parnassus Ave., HSW-450C, San Francisco, CA 94143, USA.
Cancer Metastasis Rev. 2010 Jun;29(2):309-16. doi: 10.1007/s10555-010-9223-6.
Tumor-associated myeloid cells have been implicated in regulating many of the "hallmarks of cancer" and thus fostering solid tumor development and metastasis. However, the same innate leukocytes also participate in anti-tumor immunity and restraint of malignant disease. While many factors regulate the propensity of myeloid cells to promote or repress cancerous growths, polarized adaptive immune responses by B and T lymphocytes have been identified as regulators of many aspects of myeloid cell biology by specifically regulating their functional capabilities. Here, we detail the diversity of heterogeneous B and T lymphocyte populations and their impacts on solid tumor development through their abilities to regulate myeloid cell function in solid tumors.
肿瘤相关的髓系细胞被认为在调节许多“癌症特征”方面发挥作用,从而促进实体瘤的发展和转移。然而,同样的固有白细胞也参与抗肿瘤免疫和恶性疾病的抑制。虽然许多因素调节髓系细胞促进或抑制癌变的倾向,但 B 和 T 淋巴细胞的极化适应性免疫反应被确定为调节髓系细胞生物学许多方面的调节剂,特别是通过调节其功能能力。在这里,我们详细描述了异质 B 和 T 淋巴细胞群体的多样性及其通过调节实体瘤中髓系细胞功能对实体瘤发展的影响。